Histamine H2 receptor — Drug Target
All drugs that target Histamine H2 receptor — marketed and clinical-stage. Includes 7 drug classes acting on this target.
Drug classes
Anticholinergic · ebrotidine · betazole · Histamine-2 Receptor Antagonist [EPC] · H2-receptor antagonist · H2 receptor antagonist · niperotidine
Marketed (7)
- Bentyl · Forest Labs Inc · Anticholinergic · Neuroscience
- Ebrodin · ebrotidine · Cardiovascular
- Histalog · betazole · Other
- Tagamet · Histamine-2 Receptor Antagonist [EPC] · Cardiovascular
- Famotidine (FAM) · Bristol-Myers Squibb · H2-receptor antagonist · Gastroenterology
Famotidine is a histamine H2-receptor antagonist that reduces gastric acid secretion by blocking histamine-mediated stimulation of parietal cells in the stomach. - Axid Ar · Histamine-2 Receptor Antagonist [EPC] · Cardiovascular
- Drug: cimetidine · University of Maryland, Baltimore · H2 receptor antagonist · Gastroenterology
Cimetidine blocks histamine H2 receptors on gastric parietal cells to reduce stomach acid production.
Phase 3 pipeline (2)
- H2 Receptor Antagonist · Merck Sharp & Dohme LLC · H2 receptor antagonist · Gastroenterology
H2 receptor antagonists block histamine H2 receptors on gastric parietal cells to reduce stomach acid secretion. - Cimetidine IV · Bausch Health Americas, Inc. · H2-receptor antagonist · Gastroenterology
Cimetidine is a histamine H2-receptor antagonist that reduces gastric acid secretion by blocking histamine-mediated stimulation of parietal cells.
Phase 2 pipeline (1)
- Perultid · niperotidine · Other
Perultid works by blocking histamine receptors in the stomach to reduce acid production.